ROY BARCO: Open Payments
NPI 1033436191 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 89 payments from 22 companies in 2025. Trend: 2023 $1,253 · 2024 $1,746 · 2025 $1,561
Food & beverage: $1,561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $279 |
| AstraZeneca Pharmaceuticals LP | 8 | $182 |
| Otsuka America Pharmaceutical, Inc. | 9 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| Indivior Inc. | 3 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| PFIZER INC. | 4 | $59 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Exact Sciences Corporation | 3 | $55 |
Products named: REXULTI, VRAYLAR, CAPLYTA, BREZTRI, SUBLOCADE, QULIPTA, XIFAXAN, FANAPT.
Industry payments across AL — which companies pay providers there.
